Brief report: tumor lysis syndrome following treatment with 2-chlorodeoxyadenosine for refractory chronic lymphocytic leukemia.
Dann
E J
EJ
Department of Hematology, Hadassah University Hospital, Ein Kerem, Jerusalem, Israel.
Gillis
S
S
Polliack
A
A
Okon
E
E
Rund
D
D
Rachmilewitz
E A
EA
D017338:Cladribine / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008206:Lymphatic Diseases / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D015275:Tumor Lysis Syndrome / Q000209:etiology*
D017338:Cladribine